BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10993829)

  • 1. Human Müllerian-inhibiting substance promoter contains a functional TFII-I-binding initiator.
    Morikawa N; Clarke TR; Novina CD; Watanabe K; Haqq C; Weiss M; Roy AL; Donahoe PK
    Biol Reprod; 2000 Oct; 63(4):1075-83. PubMed ID: 10993829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites.
    Watanabe K; Clarke TR; Lane AH; Wang X; Donahoe PK
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1624-9. PubMed ID: 10677509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.
    Mobley CM; Sealy L
    J Virol; 2000 Jul; 74(14):6511-9. PubMed ID: 10864664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of endogenous GATA-4 activity reveals its dual contribution to Müllerian inhibiting substance gene transcription in Sertoli cells.
    Tremblay JJ; Robert NM; Viger RS
    Mol Endocrinol; 2001 Sep; 15(9):1636-50. PubMed ID: 11518812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor GATA-4 enhances Müllerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1.
    Tremblay JJ; Viger RS
    Mol Endocrinol; 1999 Aug; 13(8):1388-401. PubMed ID: 10446911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRY recognizes conserved DNA sites in sex-specific promoters.
    Haqq CM; King CY; Donahoe PK; Weiss MA
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1097-101. PubMed ID: 8430080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade.
    Shen WH; Moore CC; Ikeda Y; Parker KL; Ingraham HA
    Cell; 1994 Jun; 77(5):651-61. PubMed ID: 8205615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MIS in the testis is downregulated by tumor necrosis factor alpha through the negative regulation of SF-1 transactivation by NF-kappa B.
    Hong CY; Park JH; Seo KH; Kim JM; Im SY; Lee JW; Choi HS; Lee K
    Mol Cell Biol; 2003 Sep; 23(17):6000-12. PubMed ID: 12917325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of mammalian sexual determination: activation of Müllerian inhibiting substance gene expression by SRY.
    Haqq CM; King CY; Ukiyama E; Falsafi S; Haqq TN; Donahoe PK; Weiss MA
    Science; 1994 Dec; 266(5190):1494-500. PubMed ID: 7985018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human KDR/flk-1 gene contains a functional initiator element that is bound and transactivated by TFII-I.
    Wu Y; Patterson C
    J Biol Chem; 1999 Jan; 274(5):3207-14. PubMed ID: 9915861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA-1 is a potential repressor of anti-Müllerian hormone expression during the establishment of puberty in the mouse.
    Beau C; Rauch M; Joulin V; Jégou B; Guerrier D
    Mol Reprod Dev; 2000 Jun; 56(2):124-38. PubMed ID: 10813843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TATA-less promoter of mouse ribonucleotide reductase R1 gene contains a TFII-I binding initiator element essential for cell cycle-regulated transcription.
    Johansson E; Skogman E; Thelander L
    J Biol Chem; 1995 Dec; 270(50):30162-7. PubMed ID: 8530424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter.
    Hossain A; Saunders GF
    Biol Reprod; 2003 Dec; 69(6):1808-14. PubMed ID: 12855602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development.
    Arango NA; Lovell-Badge R; Behringer RR
    Cell; 1999 Nov; 99(4):409-19. PubMed ID: 10571183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the human beta-globin downstream promoter region.
    Leach KM; Vieira KF; Kang SH; Aslanian A; Teichmann M; Roeder RG; Bungert J
    Nucleic Acids Res; 2003 Feb; 31(4):1292-301. PubMed ID: 12582249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for müllerian inhibiting substance.
    Lee MM; Cate RL; Donahoe PK; Waneck GL
    Endocrinology; 1992 Feb; 130(2):847-53. PubMed ID: 1346380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of the rat gene for Mullerian inhibiting substance.
    Haqq C; Lee MM; Tizard R; Wysk M; DeMarinis J; Donahoe PK; Cate RL
    Genomics; 1992 Apr; 12(4):665-9. PubMed ID: 1572639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus.
    Eichbaum QG; Iyer R; Raveh DP; Mathieu C; Ezekowitz RA
    J Exp Med; 1994 Jun; 179(6):1985-96. PubMed ID: 8195721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.